世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2014年
11期
1482-1484
,共3页
归脾汤%血液透析%贫血%血常规%血清铁蛋白
歸脾湯%血液透析%貧血%血常規%血清鐵蛋白
귀비탕%혈액투석%빈혈%혈상규%혈청철단백
Guipi Decoction%Hemodialysis%Anemia%Blood hematology%Serum ferritin
目的:观察归脾汤治疗维持性血液透析贫血患者的临床疗效。方法:将74例维持性血液透析患者根据随机数字表法分为治疗组和对照组,每组37人,对照组进行常规治疗,治疗组在常规治疗的基础上加用归脾汤,每日1剂,煎服。2组患者分别于治疗前及治疗2个疗程后采集空腹外周静脉血标本,检测红细胞压积(Hct)、血红蛋白(Hb)、红细胞计数(RBC)、转铁蛋白饱和度(Ts)、血清铁蛋白(SF)并进行比较。结果:1)治疗组3 例无效,总有效率为91.9%(34/37),明显高于对照组的73.0%,差异具有统计学意义(P <0.05)。2)2个疗程后,治疗组的 Hct 为(32.15±4.22)%,Hb 水平为(97.36±13.16)g/L,Ts 为(30.51±7.41)%,SF 的含量为(155.21±132.56)μg/L,均优于对照组,差异均具有统计学意义(P <0.05)。结论:中药归脾汤治疗维持性血液透析贫血疗效显著,可以在临床上推广应用。
目的:觀察歸脾湯治療維持性血液透析貧血患者的臨床療效。方法:將74例維持性血液透析患者根據隨機數字錶法分為治療組和對照組,每組37人,對照組進行常規治療,治療組在常規治療的基礎上加用歸脾湯,每日1劑,煎服。2組患者分彆于治療前及治療2箇療程後採集空腹外週靜脈血標本,檢測紅細胞壓積(Hct)、血紅蛋白(Hb)、紅細胞計數(RBC)、轉鐵蛋白飽和度(Ts)、血清鐵蛋白(SF)併進行比較。結果:1)治療組3 例無效,總有效率為91.9%(34/37),明顯高于對照組的73.0%,差異具有統計學意義(P <0.05)。2)2箇療程後,治療組的 Hct 為(32.15±4.22)%,Hb 水平為(97.36±13.16)g/L,Ts 為(30.51±7.41)%,SF 的含量為(155.21±132.56)μg/L,均優于對照組,差異均具有統計學意義(P <0.05)。結論:中藥歸脾湯治療維持性血液透析貧血療效顯著,可以在臨床上推廣應用。
목적:관찰귀비탕치료유지성혈액투석빈혈환자적림상료효。방법:장74례유지성혈액투석환자근거수궤수자표법분위치료조화대조조,매조37인,대조조진행상규치료,치료조재상규치료적기출상가용귀비탕,매일1제,전복。2조환자분별우치료전급치료2개료정후채집공복외주정맥혈표본,검측홍세포압적(Hct)、혈홍단백(Hb)、홍세포계수(RBC)、전철단백포화도(Ts)、혈청철단백(SF)병진행비교。결과:1)치료조3 례무효,총유효솔위91.9%(34/37),명현고우대조조적73.0%,차이구유통계학의의(P <0.05)。2)2개료정후,치료조적 Hct 위(32.15±4.22)%,Hb 수평위(97.36±13.16)g/L,Ts 위(30.51±7.41)%,SF 적함량위(155.21±132.56)μg/L,균우우대조조,차이균구유통계학의의(P <0.05)。결론:중약귀비탕치료유지성혈액투석빈혈료효현저,가이재림상상추엄응용。
Objective:To observe clinical efficacy of Guipi Decoction in the treatment of anemia in patients undergoing hemodialysis. Methods:74 hemodialysis patients were divided into treatment group and control group according to the random number table,the con-trol group used routine treatments,the treatment group used Guipi Decoction in addition to routine treatments.Hct、Hb、RBC、Ts and SF of two groups were compared.Results:1)the total effective rate of treatment group was 91.9% (34 /37),significantly higher than 73. 0% of the control group,the difference was statistically significant (P <0.05).2)After treatment,in the treatment group,the Hct was (32.15 ±4.22)%,Hb levels (97.36 ±13.16)g /L,Ts was (30.51 ±7.41)%,SF content was (155.21 ±132.56)ug /L,all were better than the control group,the differences were statistically significant (P <0.05).Conclusion:Guipi Decoction was effective for treating anemia in hemodialysis patients,it can widely used in clinical medicine.